Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00769327 · COMPLETED
Trial details
- NCT number
- NCT00769327
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-09
- Primary completion
- 2014-10-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.